Cristian M Lamaizon

Mr. Cristian M Lamaizon

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
AMAlexis Martinez
Alexis Martinez
CLCristian M Lamaizon
Cristian M Lamaizon
CVCristian Valls
Cristian Valls
FLFabien Llambi
Fabien Llambi
NLNancy Leal
Nancy Leal
Alejandra AlvarezAlejandra Alvarez
Alejandra Alvarez
The endoplasmic reticulum is a subcellular organelle key in the control of synthesis, folding, and sorting of proteins. Under endoplasmic reticulum stress, an adaptative unfolded protein response is activated; however, if this activation is prolonged, cells can undergo cell death, in part due to oxidative stress and mitochondrial fragmentation. Here, we report that endoplasmic reticulum stress activates c-Abl tyrosine kinase, inducing its translocation to mitochondria. We found that endoplasmic reticulum stress-activated c-Abl interacts with and phosphorylates the mitochondrial fusion protein MFN2, resulting in mitochondrial fragmentation and apoptosis. Moreover, the pharmacological or genetic inhibition of c-Abl prevents MFN2 phosphorylation, mitochondrial fragmentation, and apoptosis in cells under endoplasmic reticulum stress. Finally, in the amyotrophic lateral sclerosis mouse model, where endoplasmic reticulum and oxidative stress has been linked to neuronal cell death, we demonstrated that the administration of c-Abl inhibitor neurotinib delays the onset of symptoms. Our results uncovered a function of c-Abl in the crosstalk between endoplasmic reticulum stress and mitochondrial dynamics via MFN2 phosphorylation.

9 April 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
CLCristian M Lamaizon
Cristian M Lamaizon
RTRenatta Tironi-Hernández
Renatta Tironi-Hernández
NANohela B. Arévalo
Nohela B. Arévalo
SASebastián D. Ahumada
Sebastián D. Ahumada
DGDaniela Gutiérrez G
Daniela Gutiérrez G
AÁAlejandra R. Álvarez
Alejandra R. Álvarez
Gaucher disease (GD) is characterized by the accumulation of glucosylceramide within lysosomes due to mutations in the GBA1 gene, which encodes the enzyme glucocerebrosidase. Current treatments are ineffective for patients suffering from severe neuronopathic forms of the disease. In this context, new therapeutic approaches for neuronopathic GD forms are needed. Lysosomal and mitochondrial dysfunction associated with increased oxidative stress and disturbances in the autophagic process have been described in GD. Here, we address c-Abl-RIPK3 signaling and its contribution to the accumulation of dysfunctional mitochondria in GD. Fibroblasts from patients with GBA1 mutations and neurons treated with the glucocerebrosidase inhibitor CBE exhibited alterations in the ΔΨm and mitochondrial morphology, as well as reduced capacity to form autophagosomes. Pharmacological inhibition of c-Abl or RIPK3 restored mitochondrial function and promoted autophagosome formation, along with an increase in autophagic engulfment of mitochondria in both GD models. In conclusion, the c-Abl-RIPK3 signaling pathway contributes to mitochondrial dysfunction and blockade of autophagy components in the mitochondria, both of which are altered in the neuronopathic forms of GD.

19 May 2026 in BMC Biology
Verified
Journal Article
Open access
PDF file
NSNicolás Stuardo
Nicolás Stuardo
ÁCÁlvaro Cáceres-Quezada
Álvaro Cáceres-Quezada
DGDiego Guzmán
Diego Guzmán
CLCristian M Lamaizon
Cristian M Lamaizon
NRNancy Leal R.
Nancy Leal R.
AÁAlejandra R. Álvarez
Alejandra R. Álvarez
Axon initial segment (AIS) dysfunction disrupts neuronal compartmentalization, which leads to pathological processes like Tau missorting in Alzheimer’